For AbbVie’s blockbuster Humira, cheaper competitors pose surprisingly little threat, analysts say By: MarketWatch June 30, 2023 at 13:28 PM EDT Lower-price biosimilar competition for top-selling drug launching this weekend. Read More >> Related Stocks: AbbVie Amgen CVS Health Corp Cigna Corp Coherus Bio Organon & Co.
